Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04208139 · ClinicalTrials.gov registry record
A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up
A clinical trial of Recurrent Pulmonary Embolism (Disorder), sponsored by NC Heart and Vascular Research.
- Completed
- Registry status
- 11
- Enrollment target
- 1
- Study location
NCT04208139: Completed study of Recurrent Pulmonary Embolism (Disorder), sponsored by NC Heart and Vascular Research.
NCT04208139 is a study of Recurrent Pulmonary Embolism (Disorder) that has completed, run by NC Heart and Vascular Research. The registered enrollment target is 11 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04208139, a study of Recurrent Pulmonary Embolism (Disorder), has completed, sponsored by NC Heart and Vascular Research.
- COMPLETED
- Registry status
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
Conditions Studied
Interventions
- DIAGNOSTIC_TEST IVUS
Study Locations (1)
North Carolina
- NC Heart and Vascular Research, LLC - Raleigh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2020-03-14 |
| Est. Completion | 2020-10-01 |
What the finished NCT04208139 record still lists
NCT04208139 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 11 participants, a relatively small participant target.
The record links to 1 condition, with Recurrent Pulmonary Embolism (Disorder) appearing as the primary indexed condition, and to 1 intervention - of which IVUS is the first listed.
NCT04208139 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT04208139 about?
NCT04208139 is a clinical study titled "A Random Selection of Patients From the SENTRY Study Who Have a Bioconverted Sentry IVC Filter in Situ With a Minimum Dwell Time of 24 Months From a Single Center Follow up". IVUS Evaluation of the Bioabsorbable Sentry IVC Filter 3-5 Years Post Deployment Follow up
What is the current status of trial NCT04208139?
This trial is currently completed. The enrollment target is 11 participants. The study started on 2020-03-14. Estimated completion is 2020-10-01.
What conditions does trial NCT04208139 study?
This clinical trial studies the following conditions: Recurrent Pulmonary Embolism (Disorder).
What interventions are being tested in trial NCT04208139?
The interventions under investigation include: IVUS (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT04208139?
This trial is sponsored by NC Heart and Vascular Research, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04208139 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI